A proof‐of‐concept study of an automated solution for clinical metagenomic next‐generation sequencing

Abstract

This study opens up an opportunity of performing in-house mNGS to reduce turnaround time and workload, instead of transferring potentially contagious specimen to a third-party laboratory.